[1].   Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. Doi:10.1016/S0140-6736(20)30183-30183-5.

[2].   Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Emergence, transmission, and characteristics of human Coronaviruses. 2020. https://doi.org/10.1016/j.jare.2020.03.005

[3].   Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 associated with the COVID-19 Outbreak. 2020.

[4].   Perlman S. Another decade, another coronavirus. N Engl J Med. 2020. Doi:0.1056/NEJMe2001126.

[5].   Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-72.

[6].   Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-20.

[7].   Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-23. Doi: https://doi.org/10.1016/S0140-6736(20)30154-9

[8].   Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020. Doi: 10.1056/NEJMoa2001191.

[9].   Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020.

[10].  Meo SA, Klonoff DC, Akram J. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci. 2020;24(8):4539-47.

[11].  Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178:104787. Doi: 10.1016/j.antiviral.2020.104787.

[12].  Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment Coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/

[13].  Lai C, Hung Y, Wang C. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020;2:10.

[14].  Zhang Y, Yu L, Tang L, Zhu M, Jin Y, Wang Z, et al. A promising anti-cytokine-storm targeted therapy for COVID-19: the artificial-liver blood-purification system. Engineering. 2020.

[15].  Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020. DOI: 10.1056/NEJMc2001468.

[16].  Amzat J, Razum O. Toward sociology of health discourse in Africa. Cham, Switzerland: International Publication; 2018. https://link.springer.com/book/10.1007/978-3-319-61672-8?noAccess=true. Doi:10.1007/978-3-319-61672-8.

[17].  Nigeria Centre for Disease Control (NCDC). Covid-19 outbreak in Nigeria: situation report. 2020. https//ncdc.gov.ng/ng/diseases/sitreps.

[18].  The Irish Times. Coronavirus pandemic. 2020. J Infect Dis. 94:151-3. doi: 10.1016/j.ijid.2020.04.007.

[19].  Clinical Trial Arena. Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19. 2020. Retrieved from https: www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs

[20].  Galal S. Statistics on coronavirus cases in Africa, by country. 2021. https://www.statista.com/statistics/1170463/coronavirus-cases-in-africa/

[21].  Adekunle IA, Onanuga AT, Akinola OO, Ogunbanjo OW. Modelling spatial variations of coronavirus disease (COVID-19) in Nigeria. Geospat Health. 2020;15(1):87-98.

[22].  Elimian KO, Ochu CL, Ilori E, Oladejo J, Igumbor E, Steinhardt L, et al. Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February–6 June 2020. Epidemiol Infect. 2020;148:e208. https://doi.org/10.1017/S095026882000206X

[23].  World Health Organization. Strengthening the health systems response to COVID-19. Geneva: World Health Organization; 2020.

[24].  Johns Hopkins Coronavirus Resource Centre. Mortality analyses. 2020. Retrieved from https://coronavirus.jhu.edu/data/mortality

[25].  World Health Organization Africa. Weekly bulletin on outbreaks and other emergencies: Week 23. 2020. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/332302/OEW23-0107062020.pdf

[26].  Patel SK, Velkoska E, Burrell LM. Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in? Clin Exp Pharmacol Physiol. 2013;40(8):551-9. Doi:10.1111/1440-1681.12069.

[27].  Akanle O, Adesina J, Waobiala UR. Turbulent but I must endure in silence: female breadwinners and survival in southwestern Nigeria. J Asian Afr Stud. 2018;53(1):98-114. Doi:10.1177/0021909616658913.

[28].  Kang L, Ma S, Chen M, Yang J, Wang Y, Li R, et al. Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: a cross-sectional study. Brain Behav Immun. 2020;87:11-7. https://doi.org/10.1016/j.bbi.2020.03.028

[29].  Chanda-Kapata P, Kapata N, Zumla A. COVID-19 and malaria: a potentially dangerous combination. Int J Infect Dis. 2020;94:151-3. WHO: Malaria factsheet. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/malaria

[30].  World Health Organization. Malaria factsheet. 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/malaria

[31].  Barranco R, Vallega Bernucci Du Tremoul L, Ventura F. Hospital-acquired SARS-CoV-2 infections in patients: inevitable conditions or medical malpractice? Int J Environ Res Public Health. 2021;18:489.

[32].  Menon V, Padhy SK, Pattnaik JI. Stigma and aggression against health care workers in India amidst COVID-19 times: possible drivers and mitigation strategies. Indian J Psychol Med. 2020;42(4):400-1. Doi:10.1177/0253717620929241.

[33].  Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):779-88. Doi:10.1016/j.dsx.2020.05.035.

[34].  Verma S, Mythily S, Chan YH, Deslypere JP, Teo EK, Chong SA. Post-SARS psychological morbidity and stigma among general practitioners and traditional Chinese medicine practitioners in Singapore. Ann Acad Med Singap. 2004;33(6):743-8.

[35].  Asmundson GJG, Taylor S. Coronaphobia: fear and the 2019-nCoV outbreak [Internet]. J Anxiety Disord. 2020;70. Available from: https://pubmed.ncbi.nlm.nih.gov/32078967/

[36].  In Nigeria, vaccine hesitancy and non-compliance hindering herd immunity-2. 2020.

[37].  Reiter PL, Pennell ML, Katz ML. Acceptability of COVID-19 vaccine among adults in the United States: how many people will get vaccinated? Vaccine. 2020;38(42):6500-7. Doi:10.1016/j.vaccine.2020.08.043.

[38].  Salam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rate. Vaccines (Basel). 2021;9(2):160. Doi:10.3390/vaccines9020160.

[39].  Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. Fair allocation of scarce medical resources in the time of COVID-19. N Engl J Med. 2020;382(21):2049-55. Doi:10.1056/NEJMsb2005114.

[40].  Mehrotra A, Chernew M, Linetsky D, Hatch H, Cutler D. What impact has COVID-19 had on outpatient visits? To The Point. 2020.